Search clinical trials for: ARC1779

Total 6 results

Archemix Corp.

Withdrawn

A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B

Von Willebrand Disease
Archemix Corp.

Completed

Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers

Thrombosis

United States
Archemix Corp.

Terminated

Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy

Thrombotic Thrombocytopenic Purpura | Thrombotic Microangiopathy

United States, Italy, Austria, Canada, United Kingdom
Archemix Corp.

Completed

ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders

Purpura, Thrombotic Thrombocytopenic | Von Willebrand Disease Type-2b

Austria
Archemix Corp.
St George's, University of London

Terminated

Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy

Carotid Stenosis | Intracranial Embolism | Cerebral Thromboembolism

United States, United Kingdom
Chen Ying

Enrolling by invitation

Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis

Sepsis

China

3

Subscribe